These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1364893)

  • 1. [Treatment and follow-up of thyroid cancer].
    Välimäki M
    Duodecim; 1991; 107(6):456-60. PubMed ID: 1364893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medullary carcinoma of the thyroid gland].
    Zarrilli L; Marzano LA; Porcelli A; Zarrilli S; D'Ajello M
    Chir Ital; 1994; 46(4):33-6. PubMed ID: 7882440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
    Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
    Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
    Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphology and clinical picture of thyroid cancer].
    Meng W; Lorenz G
    Z Arztl Fortbild (Jena); 1983; 77(15):635-8. PubMed ID: 6356642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of markers in the diagnosis and follow-up of thyroid carcinomas].
    Carmignani F; Piscopello L; Sammartini C
    Chir Ital; 1994; 46(4):42-5. PubMed ID: 7882442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of differentiated thyroid cancer].
    Hubold C; Buchmann I; Lehnert H
    Dtsch Med Wochenschr; 2011 Apr; 136(17):891-5. PubMed ID: 21523640
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
    Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
    Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of thyroid cancer.
    Halnan KE
    Ann Radiol (Paris); 1977; 20(8):826-30. PubMed ID: 610557
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of medullary thyroid carcinoma].
    Raue F
    Dtsch Med Wochenschr; 1985 Aug; 110(35):1337-9. PubMed ID: 2992904
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioiodine therapy and age at menopause in patients with thyroid cancer.
    Rosario PW; Fagundes TA; Fagundes AV; Barraso AL; Rezende LL; Padrao EL; Guimaraes VC; Purisch S
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):225-6. PubMed ID: 16430725
    [No Abstract]   [Full Text] [Related]  

  • 13. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant thyrotropin.
    Toft A; Beckett G
    Lancet; 2002 Jun; 359(9321):1874-5. PubMed ID: 12057547
    [No Abstract]   [Full Text] [Related]  

  • 15. Contemporary management of papillary carcinoma of the thyroid gland.
    Rosenbaum MA; McHenry CR
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
    Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
    Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid cancer causing death after 40 years: rationale for initial intensive treatment.
    Powell S; Harmer C
    Eur J Surg Oncol; 1990 Oct; 16(5):457-61. PubMed ID: 2209842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of thyroid tumors.
    DeGroot LJ
    Ann Clin Lab Sci; 1983; 13(2):77-82. PubMed ID: 6305255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.